Related Experiment Video
Updated: May 14, 2026

06:06
Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
Decrease recurrence rate of condylomata acuminata by photodynamic therapy combined with CO2 laser in mainland China:
Xiaoling Zhu1, Hongxiao Chen, Longfeng Cai
1Department of Pathology, Basic Medical Science College, Harbin Medical University, Harbin, China.
Summary
5-aminolaevulinic acid photodynamic therapy (ALA-PDT) combined with CO2 laser significantly reduces condylomata acuminata (CA) recurrence compared to CO2 laser alone. This combination therapy shows promise for effective CA treatment.
Area of Science:
- Dermatology
- Oncology
- Photomedicine
Background:
- Condylomata acuminata (CA) are genital warts caused by human papillomavirus (HPV).
- Conventional treatments for CA often result in high rates of recurrence.
- Novel therapeutic strategies are needed to improve CA treatment outcomes.
Purpose of the Study:
- To compare the recurrence rates of 5-aminolaevulinic acid photodynamic therapy (ALA-PDT) combined with CO2 laser versus CO2 laser alone for CA treatment.
- To evaluate the efficacy of ALA-PDT in reducing CA recurrence in mainland China.
Main Methods:
- A meta-analysis was conducted on 2,048 cases of CA from 22 published articles.
- Patients were divided into a treatment group (ALA-PDT + CO2 laser) and a control group (CO2 laser alone).
- Recurrence rates between the two groups were statistically compared.
Main Results:
- The recurrence rate in the control group (CO2 laser alone) was 42.67% (451/1,057).
- The recurrence rate in the treatment group (ALA-PDT + CO2 laser) was significantly lower at 10.29% (102/991).
- The difference in recurrence rates was statistically significant (χ(2) = 271.98, p < 0.0001).
Conclusions:
- ALA-PDT combined with CO2 laser is more effective than CO2 laser alone in reducing the recurrence of condylomata acuminata.
- This combination therapy demonstrates potential for widespread clinical application in managing CA.
- Further research may explore long-term efficacy and patient-reported outcomes.
